Researchers at the Massachusetts Institute of Technology have developed a noninvasive diagnostic technique called RamanOmics, combining laser microscopy and single-cell RNA sequencing to detect senescent zombie cells
in animal tissue without destroying them, according to a study published in Nature Aging.
As organisms age, certain cells permanently halt division without undergoing programmed cell death. These so-called zombie cells linger in tissues, spewing inflammatory molecules that damage surrounding structures and contribute to age-related conditions including osteoarthritis, type 2 diabetes, tissue degeneration, and cancer. Yet these same cells perform essential physiological roles during embryonic development and tissue regeneration.
How RamanOmics Maps the Biochemical Architecture of Aging
The newly unveiled RamanOmics platform solves that destruction problem by pairing non-destructive Raman microscopy with spatial transcriptomics. While traditional RNA-sequencing consumes biological samples during analysis, Raman microscopy shines near-infrared or visible light onto intact cells, revealing their complete biochemical composition through scattered light spectra without harming them.
To build and validate the system, researchers collected lung and skin tissue samples from young mice aged 2 months and old mice aged 26 months. They then used imaging-based spatial transcriptomics, mapping cell states across a curated panel of 890 genes that included 700 cell-type markers and 190 senescence-specific markers.
“Our idea was to look at many different features to characterize senescence. That’s why we wanted to combine both single-cell gene expression and Raman microscopy, so that we can characterize the senescence from two complementary views.”
Jian Shu, assistant professor at Massachusetts General Hospital, Harvard Medical School, and associate member of the Broad Institute and Ragon Institute
By integrating full-spectrum Raman signatures spanning 600 to 1,800 cm−1 with spatial transcriptomic anchors, the joint team generated predictive molecular barcodes. These barcodes classify senescent and non-senescent cells across complex tissue architectures with single-cell resolution.
Tissue-Specific Discoveries
The multimodal analysis uncovered sharp physiological shifts between young and aged tissues.
Peter So, director of the MIT Laser Biomedical Research Center and a professor of biological engineering and mechanical engineering, emphasized the dual nature of these discoveries. Senescence is not just a pathological condition,
So noted, explaining that the research operates under the broader umbrella of the National Institutes of Health Cellular Senescence Network. The initiative aims to build a comprehensive map of senescence because the process underpins both normal physiological function and severe pathology.
Precision Anti-Aging Interventions and the Endoscope Horizon
Although the current work was performed in mouse models, the research group is actively working to adapt the technique for human tissue.
“You can imagine that one day we may develop an endoscope that can look inside your body and identify cellular senescence.”
Jeon Woong Kang, MIT research scientist
What Remains Uncertain as Global Dementia and Aging Costs Climb
These diagnostic and therapeutic advances address a staggering demographic challenge. Dementias of aging currently claim 46 million people worldwide, with patient populations projected to double every 20 years. Global care costs have reached an estimated $604 billion annually, while Alzheimer’s care alone in the United States is projected to total $1.1 trillion by 2050.
Significant scientific hurdles remain before these laboratory breakthroughs translate into standard clinical practice. Researchers still lack universally specific biomarkers that cleanly differentiate beneficial senescent cells involved in tissue repair from maladaptive ones driving chronic illness.